Published • loading... • Updated
GLP-1 Drugs Drive the 'Economy of Satiety' and Change the Range of the Supermarket
Summary by Merca2.es
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
GLP-1 drugs, such as Ozempic or Wegovy, have gone from being a medical treatment to becoming a silent engine that is rewriting supermarket rules. Its ability to reduce appetite – with decreases above 15-20% in daily calorie intake – is causing millions of consumers to buy less volume, choose with more judgment and stop filling the cart with products that were previously automatic. The drug that ‘domesticates’ appetite and redeems the basket The …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
